Melinda Gates sees US govt donating coronavirus vaccine doses soon

In her first remarks since divorce with Bill Gates, Melinda said governments were waking up to arguments that the global economy needs to be vaccinated to bring the pandemic under control

Melinda Gates
Melinda Gates. Photo: Bloomberg
Reuters
2 min read Last Updated : May 04 2021 | 6:55 PM IST
Melinda Gates, co-founder of one of the world's largest private charitable foundations, expects the U.S. government will soon weigh up how much of its vaccine supply to donate bilaterally and through the global COVAX programme.
 
In her first remarks to be broadcast since she and her husband, Microsoft Corp co-founder Bill Gates, announced they would divorce after 27 years, Gates said governments were waking up to arguments that the global economy needs to be vaccinated to bring the pandemic under control.
 
"I think the U.S. government is looking at their supply of vaccine and deciding, okay how much should we do through COVAX, how much should we do bilaterally, so I think you're going to start to see some movement there," Gates said in an interview with the Financial Times recorded before the divorce announcement.
 
Wealthy nations did not need to vaccinate down to their teen populations before they started sharing doses with low-income countries, Gates said, and suggested governments should pick an age range, somewhere between 20 and 30, when they would start donating vaccines.
 
The Bill & Melinda Gates Foundation has become one of the most powerful and influential forces in global public health, and last year committed about $1.75 billion to COVID-19 relief.
 
The 56-year-old Texas-raised computer scientist, who met Bill Gates, 65, at a company dinner in New York, will continue to run the foundation with him.
 
Gates was cool on the idea of waiving intellectual property rights to help increase vaccine supply, saying it made more sense to incentivise pharmaceutical companies to carry out technology transfers.
 
"The piece that is not working today is the manufacturing," she said. "We don't have enough raw materials, we don't have enough manufacturing in the right places, so it is allowing the nations that have manufacturing in place to hoard their vaccines, so we got to fix that piece."

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :Coronaviruspublic healthCoronavirus Vaccine

Next Story